Luis E. Rodrı́guez

3.0k total citations
60 papers, 1.7k citations indexed

About

Luis E. Rodrı́guez is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Oncology. According to data from OpenAlex, Luis E. Rodrı́guez has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 20 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Luis E. Rodrı́guez's work include Malaria Research and Control (28 papers), Mosquito-borne diseases and control (12 papers) and HIV Research and Treatment (11 papers). Luis E. Rodrı́guez is often cited by papers focused on Malaria Research and Control (28 papers), Mosquito-borne diseases and control (12 papers) and HIV Research and Treatment (11 papers). Luis E. Rodrı́guez collaborates with scholars based in Colombia, United States and Chile. Luis E. Rodrı́guez's co-authors include Manuel E. Patarroyo, Hernando Curtidor, Marisol Ocampo, Mauricio Urquiza, Ricardo Vera, Ramsés López, Cherrie K. Donawho, Álvaro Puentes, Javier Eduardo García‐Castañeda and Fanny Guzmán and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Luis E. Rodrı́guez

59 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis E. Rodrı́guez Colombia 22 841 673 530 376 207 60 1.7k
Alexis Kaushansky United States 24 564 0.7× 854 1.3× 247 0.5× 307 0.8× 237 1.1× 57 1.6k
Eric H. Ekland United States 15 851 1.0× 508 0.8× 845 1.6× 1.9k 5.1× 146 0.7× 20 3.2k
Sharon Yeoh United Kingdom 15 640 0.8× 647 1.0× 273 0.5× 301 0.8× 159 0.8× 23 1.6k
Kazimiera Waśniowska Poland 19 590 0.7× 459 0.7× 229 0.4× 557 1.5× 95 0.5× 47 1.4k
Edelmira Cabezas United States 12 1.1k 1.4× 196 0.3× 114 0.2× 386 1.0× 101 0.5× 13 1.7k
Scott E. Lindner United States 25 723 0.9× 1.1k 1.7× 197 0.4× 617 1.6× 318 1.5× 60 1.8k
Anton R. Dluzewski United Kingdom 31 666 0.8× 1.9k 2.8× 225 0.4× 710 1.9× 460 2.2× 51 2.7k
Jay R. Hesselberth United States 31 2.5k 3.0× 263 0.4× 220 0.4× 669 1.8× 234 1.1× 69 3.7k
Hua-Poo Su United States 20 583 0.7× 113 0.2× 337 0.6× 676 1.8× 380 1.8× 33 1.7k
Grazia Camarda Italy 17 546 0.6× 598 0.9× 231 0.4× 423 1.1× 171 0.8× 23 1.3k

Countries citing papers authored by Luis E. Rodrı́guez

Since Specialization
Citations

This map shows the geographic impact of Luis E. Rodrı́guez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis E. Rodrı́guez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis E. Rodrı́guez more than expected).

Fields of papers citing papers by Luis E. Rodrı́guez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis E. Rodrı́guez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis E. Rodrı́guez. The network helps show where Luis E. Rodrı́guez may publish in the future.

Co-authorship network of co-authors of Luis E. Rodrı́guez

This figure shows the co-authorship network connecting the top 25 collaborators of Luis E. Rodrı́guez. A scholar is included among the top collaborators of Luis E. Rodrı́guez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis E. Rodrı́guez. Luis E. Rodrı́guez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chervin, Adam S., Jennifer D. Stone, Iwona Konieczna, et al.. (2023). ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies. Molecular Cancer Therapeutics. 22(8). 903–912. 7 indexed citations
2.
Anderson, Mark G., Qian Zhang, Luis E. Rodrı́guez, et al.. (2021). ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition. BMC Cancer. 21(1). 681–681. 9 indexed citations
3.
Guillot, Sébastien, George G. Pavlov, Andreas Reisenegger, et al.. (2019). Hubble Space Telescope Nondetection of PSR J2144–3933: The Coldest Known Neutron Star. The Astrophysical Journal. 874(2). 175–175. 33 indexed citations
4.
Rodrı́guez, Luis E., et al.. (2016). Body mass index and clinical and pathological characteristics of breast cancer patients. Revista cubana de endocrinología. 27(3). 45–62. 1 indexed citations
5.
Hopkins, Todd A., Yan Shi, Luis E. Rodrı́guez, et al.. (2015). Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors. Molecular Cancer Research. 13(11). 1465–1477. 198 indexed citations
6.
Rodrı́guez, Luis E., et al.. (2012). Surprises from an Unusual CLC Homolog. Biophysical Journal. 103(9). L44–L46. 15 indexed citations
7.
Palma, Joann P., Yichun Wang, Luis E. Rodrı́guez, et al.. (2009). ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors. Clinical Cancer Research. 15(23). 7277–7290. 111 indexed citations
8.
Guo, Jun, Paul Tapang, Joann P. Palma, et al.. (2009). Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152. The Pharmacogenomics Journal. 9(2). 90–102. 27 indexed citations
9.
Patarroyo, Manuel A., David Fernando Plaza, Marisol Ocampo, et al.. (2008). Functional characterization of Mycobacterium tuberculosis Rv2969c membrane protein. Biochemical and Biophysical Research Communications. 372(4). 935–940. 11 indexed citations
10.
Liu, Xuesong, Joann P. Palma, Robert J. Kinders, et al.. (2008). An enzyme-linked immunosorbent poly(ADP-ribose) polymerase biomarker assay for clinical trials of PARP inhibitors. Analytical Biochemistry. 381(2). 240–247. 32 indexed citations
11.
Reyes, Claudia, et al.. (2007). Functional, structural, and immunological compartmentalisation of malaria invasive proteins. Biochemical and Biophysical Research Communications. 354(2). 363–371. 21 indexed citations
12.
Puentes, Álvaro, Jimena Cortés, Ricardo Vera, et al.. (2005). Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells. Protein Science. 14(11). 2767–2780. 23 indexed citations
13.
Ocampo, Marisol, Luis E. Rodrı́guez, Hernando Curtidor, et al.. (2005). Identifying Plasmodium falciparum cytoadherence‐linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes. Protein Science. 14(2). 504–513. 16 indexed citations
14.
Vera, Ricardo, Marisol Ocampo, Javier Eduardo García‐Castañeda, et al.. (2005). Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochimie. 87(5). 425–436. 8 indexed citations
15.
García‐Castañeda, Javier Eduardo, Álvaro Puentes, Hernando Curtidor, et al.. (2005). Peptides from the Plasmodium falciparum STEVOR putative protein bind with high affinity to normal human red blood cells. Peptides. 26(7). 1133–1143. 16 indexed citations
16.
Vera, Ricardo, Elizabeth Aparecida Ferraz da Silva Torres, Marisol Ocampo, et al.. (2005). Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines. Biochemical and Biophysical Research Communications. 332(3). 771–781. 18 indexed citations
17.
Vera, Ricardo, Marisol Ocampo, Ramsés López, et al.. (2004). Identifying Plasmodium falciparum EBA-175 homologue sequences that specifically bind to human erythrocytes. Biochemical and Biophysical Research Communications. 321(4). 835–844. 5 indexed citations
18.
Ocampo, Marisol, Hernando Curtidor, Ricardo Vera, et al.. (2004). MAEBL Plasmodium falciparum protein peptides bind specifically to erythrocytes and inhibit in vitro merozoite invasion. Biochemical and Biophysical Research Communications. 315(2). 319–329. 16 indexed citations
19.
Puentes, Álvaro, Javier Eduardo García‐Castañeda, Ricardo Vera, et al.. (2003). Sporozoite and Liver Stage Antigen Plasmodium falciparum peptides bind specifically to human hepatocytes. Vaccine. 22(9-10). 1150–1156. 14 indexed citations
20.
Curtidor, Hernando, Mauricio Urquiza, Jorge Suárez, et al.. (2001). Plasmodium falciparum acid basic repeat antigen (ABRA) peptides: erythrocyte binding and biological activity. Vaccine. 19(31). 4496–4504. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026